Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Block Drug Sales Up 3.4% To $822.4 Mil. In FY 1999, Fueled By Acquisitions

This article was originally published in The Tan Sheet

Executive Summary

Block Drug sales for the year ended March 31 climbed 3.4% to $822.4 mil., bolstered by "important acquisitions and new product introductions," the company said June 8. The sales figure excludes the effects of the divestiture of three household products in the fiscal first quarter and the strong U.S. dollar, Block noted. After accounting for those effects, net sales actually declined 4.9% to $821.1 mil.
Advertisement

Related Content

Phazyme Anti-Gas Franchise Expands With Ultra Strength Softgel
Phazyme Anti-Gas Franchise Expands With Ultra Strength Softgel
Phazyme Anti-Gas Franchise Expands With Ultra Strength Softgel

Topics

Advertisement
UsernamePublicRestriction

Register

PS089947

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel